Skip to content
Peptilyze
Growth hormone axis

GHRP-6 studies

676 journal papers mention GHRP-6 in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether GHRP-6 is safe, effective or approved for any use.

Compare GHRP-6 prices, from €11.99 →

Papers
676
666 articles, 10 reviews
Earliest paper
1988
Most papers in 2011 (32)
Open access
31%
free to read somewhere
Reviews
1%
of all papers listed

What kind of studies

Of 639 papers in PubMed that mention GHRP-6 in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials19
  • Other clinical trials23
  • Meta-analyses and systematic reviews0
  • Other reviews28
  • Case reports5
  • Animal studies only351
  • Studies in humans234

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Papers per year

1997 to 2026, peak 32 papers in a year. The latest year may still be incomplete.

1997: 22 papers1998: 26 papers1999: 19 papers2000: 13 papers2001: 15 papers2002: 16 papers2003: 24 papers2004: 14 papers2005: 23 papers2006: 22 papers2007: 24 papers2008: 31 papers2009: 20 papers2010: 24 papers2011: 32 papers2012: 27 papers2013: 23 papers2014: 22 papers2015: 22 papers2016: 14 papers2017: 27 papers2018: 17 papers2019: 21 papers2020: 12 papers2021: 16 papers2022: 9 papers2023: 9 papers2024: 13 papers2025: 18 papers2026: 15 papers19972026

Where it is published

  1. Peptides34 papers
  2. Endocrinology28 papers
  3. Clinical Endocrinology22 papers
  4. The Journal of Clinical Endocrinology & Metabolism22 papers
  5. Journal of Endocrinology21 papers

The papers

Most citedName in the title

No papers in this list match the filter.

LatestName in title or abstract

  1. Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review

    V Vasylieva, Annette West, Edward Karpman · Sexual Medicine Reviews · 2026

    Review

  2. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

    Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz et al. · Frontiers in Endocrinology · 2026

    ReviewOpen access · CC BY1 citationsRead the open copy →

Each list shows up to 40 papers.See all 676 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.